Virax Biolabs Group Ltd.
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$0.19avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Virax Biolabs Group Ltd. in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Farther Finance Advisors, LLC ($4).
- Company
- Virax Biolabs Group Ltd.
- CUSIP
- G9495L109
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Farther Finance Advisors, LLC | 0.00% | No change | 21 | $4 |
"% of holder's portfolio" is VIRAX BIOLABS GROUP LTD's weight in each manager's 13F, not the share of Virax Biolabs Group Ltd. the manager owns.